These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 16769661)

  • 1. Anti-Jo-1 antibody positive polymyositis--successful therapy with leflunomide.
    Lange U; Piegsa M; Müller-Ladner U; Strunk J
    Autoimmunity; 2006 May; 39(3):261-4. PubMed ID: 16769661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The anti-Jo-1 syndrome - a specific form of myositis with interstitial lung disease].
    Häussermann A; Gillissen A; Seidel W
    Pneumologie; 2010 Aug; 64(8):496-503. PubMed ID: 20387195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interstitial alveolitis as early manifestation of anti-Jo-1 positive polymyositis.
    Löhr HF; Böcher WO; Hermann E; Müller-Quernheim J; Schwickert H; Meyer zum Büschenfelde KH; Gerken G
    Z Rheumatol; 1993; 52(5):307-11. PubMed ID: 8259723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The shades of anti-Jo1 positive antisynthetase syndrome in a Hungarian cohort].
    Szabó K; Nagy-Vincze M; Bodoki L; Hodosi K; Dankó K; Griger Z
    Orv Hetil; 2016 Apr; 157(15):575-83. PubMed ID: 27039996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-synthetase syndrome: a special subgroup of idiopathic inflammatory myopathies. Apropos of 3 case reports].
    Perret L; Salani I; Rivier G; So AK
    Praxis (Bern 1994); 1996 Apr; 85(16):508-12. PubMed ID: 8657993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome of patients with polymyositis/ dermatomyositis and anti-PM-Scl antibody.
    Marie I; Lahaxe L; Benveniste O; Delavigne K; Adoue D; Mouthon L; Hachulla E; Constans J; Tiev K; Diot E; Levesque H; Boyer O; Jouen F
    Br J Dermatol; 2010 Feb; 162(2):337-44. PubMed ID: 19845665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical implications of autoantibody screening in patients with autoimmune myositis.
    Ghirardello A; Zampieri S; Tarricone E; Iaccarino L; Bendo R; Briani C; Rondinone R; Sarzi-Puttini P; Todesco S; Doria A
    Autoimmunity; 2006 May; 39(3):217-21. PubMed ID: 16769655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful combination therapy of cyclosporine and methotrexate for refractory polymyositis with anti-Jo-1 antibody: a case report.
    Chang HK; Lee DH
    J Korean Med Sci; 2003 Feb; 18(1):131-4. PubMed ID: 12589104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical features and misdiagnosis of anti-Jo-1 syndrome: analysis of 33 cases].
    Zheng WJ; Wei W; Tang FL
    Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(18):1565-8. PubMed ID: 14642109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features and prognosis of patients with idiopathic inflammatory myopathies and anti-Jo-1 antibodies.
    Mielnik P; Wiesik-Szewczyk E; Olesinska M; Chwalinska-Sadowska H; Zabek J
    Autoimmunity; 2006 May; 39(3):243-7. PubMed ID: 16769658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody to Jo-1 in polymyositis/dermatomyositis: association with interstitial pulmonary disease.
    Hochberg MC; Feldman D; Stevens MB; Arnett FC; Reichlin M
    J Rheumatol; 1984 Oct; 11(5):663-5. PubMed ID: 6334746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The type I interferon system in idiopathic inflammatory myopathies.
    Lundberg IE; Helmers SB
    Autoimmunity; 2010 Apr; 43(3):239-43. PubMed ID: 20187702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-Jo-1-positive polymyositis with interstitial alveolitis and pericardial effusion. Overview of 3 years treatment].
    Krajnc I
    Wien Klin Wochenschr; 1995; 107(19):590-2. PubMed ID: 7502505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The antisynthetase syndrome: a cause of rapidly progressive interstitial lung disease].
    Jordan Greco AS; Métrailler JC; Dayer E
    Rev Med Suisse; 2007 Nov; 3(134):2675-6, 2679-81. PubMed ID: 18159702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-Jo-1 antibodies: specific autoantibodies for polymyositis with interstitial pulmonary fibrosis. 2 case reports].
    Fischer E; Thiele A; Stierle HE; Lang B
    Z Rheumatol; 1995; 54(3):171-7. PubMed ID: 7660688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Polymyositis and Jo-1 syndrome].
    Treher E; Niederhoff A; Gellissen U; Schmidt P; Dornberg M; Peter HH
    Z Rheumatol; 1993; 52(5):301-6. PubMed ID: 8259722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sera from anti-Jo-1-positive patients with polymyositis and interstitial lung disease induce expression of intercellular adhesion molecule 1 in human lung endothelial cells.
    Barbasso Helmers S; Englund P; Engström M; Ahlin E; Fathi M; Janciauskiene S; Heimbürger M; Rönnelid J; Lundberg IE
    Arthritis Rheum; 2009 Aug; 60(8):2524-30. PubMed ID: 19644880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Jo-1 antibody in patients with polymyositis/dermatomyositis.
    Leu CC; Lan JL
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Feb; 25(1):41-7. PubMed ID: 1306148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisynthetase syndrome.
    Katzap E; Barilla-LaBarca ML; Marder G
    Curr Rheumatol Rep; 2011 Jun; 13(3):175-81. PubMed ID: 21455765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In patients with antisynthetase syndrome the occurrence of anti-Ro/SSA antibodies causes a more severe interstitial lung disease.
    La Corte R; Lo Mo Naco A; Locaputo A; Dolzani F; Trotta F
    Autoimmunity; 2006 May; 39(3):249-53. PubMed ID: 16769659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.